1. Home
  2. ONCO vs LCFY Comparison

ONCO vs LCFY Comparison

Compare ONCO & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCO
  • LCFY
  • Stock Information
  • Founded
  • ONCO 2018
  • LCFY 2009
  • Country
  • ONCO United States
  • LCFY Australia
  • Employees
  • ONCO N/A
  • LCFY N/A
  • Industry
  • ONCO Biotechnology: Pharmaceutical Preparations
  • LCFY
  • Sector
  • ONCO Health Care
  • LCFY
  • Exchange
  • ONCO Nasdaq
  • LCFY Nasdaq
  • Market Cap
  • ONCO 9.4M
  • LCFY 9.9M
  • IPO Year
  • ONCO 2022
  • LCFY 2022
  • Fundamental
  • Price
  • ONCO $0.54
  • LCFY $7.48
  • Analyst Decision
  • ONCO
  • LCFY
  • Analyst Count
  • ONCO 0
  • LCFY 0
  • Target Price
  • ONCO N/A
  • LCFY N/A
  • AVG Volume (30 Days)
  • ONCO 9.9M
  • LCFY 20.6K
  • Earning Date
  • ONCO 04-10-2025
  • LCFY 04-01-2025
  • Dividend Yield
  • ONCO N/A
  • LCFY N/A
  • EPS Growth
  • ONCO N/A
  • LCFY N/A
  • EPS
  • ONCO N/A
  • LCFY N/A
  • Revenue
  • ONCO $1,870,605.00
  • LCFY $2,668,385.00
  • Revenue This Year
  • ONCO N/A
  • LCFY N/A
  • Revenue Next Year
  • ONCO N/A
  • LCFY N/A
  • P/E Ratio
  • ONCO N/A
  • LCFY N/A
  • Revenue Growth
  • ONCO N/A
  • LCFY N/A
  • 52 Week Low
  • ONCO $0.32
  • LCFY $2.20
  • 52 Week High
  • ONCO $21.40
  • LCFY $11.23
  • Technical
  • Relative Strength Index (RSI)
  • ONCO 43.36
  • LCFY 49.98
  • Support Level
  • ONCO $0.53
  • LCFY $5.80
  • Resistance Level
  • ONCO $0.70
  • LCFY $8.00
  • Average True Range (ATR)
  • ONCO 0.06
  • LCFY 0.67
  • MACD
  • ONCO 0.00
  • LCFY -0.11
  • Stochastic Oscillator
  • ONCO 15.40
  • LCFY 46.80

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

About LCFY Locafy Limited

Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.

Share on Social Networks: